Anxiety, Distress-based Psychopathology, Mental Disorder, Stress
Conditions
Brief summary
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
Detailed description
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
Interventions
BEHAVIORALAcceptance and commitment therapy
Acceptance and commitment therapy is a psychotherapy focused at increasing psychological flexibility and an individual\'s engagement in valued activities rather than focusing solely or primarily on reducing psychiatric symptoms
Sponsors
University of Alabama at Birmingham
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Pre-post design with single group of participants who will each receive the treatment
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* identify as a man * be at least 18 years old * has been diagnosed with HIV by a healthcare professional
Exclusion criteria
* has engaged in self-harm within the last three months * has attempted suicide within the last year * has had an active plan to attempt suicide within the last 30 days * is currently diagnosed with any eating disorder * has experienced hallucinations or delusions within the last 30 days * has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient Health Questionnaire-9 Screener | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of depressive symptoms |
| PTSD Checklist-5 | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of post-traumatic stress symptoms |
| Yale-Brown Obsessive Compulsive Scale | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of obsessive-compulsive disorder symptoms |
| Alcohol Use Disorders Identification Test | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of alcohol use |
| HIV stigma scale | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of facets of stigma experienced by individuals with HIV |
| Internalized homophobia scale | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of internalized homophobia |
| Brief pornography screen | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of concerning pornography use |
| Life Quality Scale | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of life quality |
| Experiential Avoidance Rating Scale | Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of experiential avoidance |
| National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of drug use |
| High risk sexual behaviors | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | * Frequency of sex with penetration * Frequency of condom use * Frequency of oral sex * Frequency of sexual partners |
| Generalized Anxiety Disorder-7 Screener | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of anxiety symptoms |
| PSYFLEX | Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of psychological flexibility |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Therapeutic Alliance Scale | Administered immediately after final intervention session (8th/final session; each session is 1 hour) | Measure of patient and therapist alliance |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORNicholas Borgogna, PhD
University of Alabama at Birmingham
PRINCIPAL_INVESTIGATORDrew Whittington, MS, MA
University of Alabama at Birmingham
Outcome results
None listed